← FDA DRUG APPROVALS

FDA ANDA · ANDA091671

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX

Sponsor: NEOS THERAPS INC

APPLICATION
ANDA091671
TYPE
ANDA
ORIGINAL APPROVAL
2012-06-29
LATEST ACTION
2015-11-20
ROUTE
ORAL
DOSAGE FORM
SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREXDiscontinued
CHLORPHENIRAMINE POLISTIREX EQ 8MG MALEATE/5ML, HYDROCODONE POLISTIREX EQ 10MG BITARTRATE/5ML · SUSPENSION, EXTENDED RELEASE · ORAL

Approval history

2015-11-20Manufacturing (CMC) · Supplement 5 · unknownAP
2012-06-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →